Management of neurobrocellosis: An assessment of 11 cases

Internal Medicine

Volumn 47, Issue 11, 2008, Pages 995-1001

  Gul, Hanefi Cem ^a   Erdem, Hakan ^a   Gorenek, Levent ^a   Ozdag, Mehmet Fatih ^a   Kalpakci, Yasin ^a   Avci, Ismail Yasar ^a   Besirbellioglu, Bulent Ahmet ^b   Eyigun, Can Polat ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b NONE

Author keywords

Complications; Neurobrucellosis; Therapy

Indexed keywords

CEFTRIAXONE; COTRIMOXAZOLE; DOXYCYCLINE; RIFAMPICIN; ANTIINFECTIVE AGENT;

ADULT; ANAMNESIS; ARTICLE; BACTERIUM ISOLATION; BRUCELLA MELITENSIS; BRUCELLOSIS; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CLINICAL PROTOCOL; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DRUG CHOICE; FEMALE; HEARING LOSS; HUMAN; MALE; NEUROBRUCELLOSIS; NONHUMAN; SEROLOGY; SUBARACHNOID HEMORRHAGE; WALKING DIFFICULTY; CASE REPORT; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID; MIDDLE AGED; TURKEY (REPUBLIC);

ADULT; ANTI-BACTERIAL AGENTS; BRUCELLOSIS; CEFTRIAXONE; CENTRAL NERVOUS SYSTEM BACTERIAL INFECTIONS; DOXYCYCLINE; FEMALE; HUMANS; MALE; MIDDLE AGED; RIFAMPIN; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; TURKEY;

EID: 48249140669     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.47.0866     Document Type: Article

References (40)

1. Godfroid J, Cloeckaert A, Liautard JP, et al. From the discovery of the Malta fever's agent to the discovery of a marine mammal reservoir, brucellosis has continuously been a re-emerging zoonosis. Vet Res 36: 313-326, 2005.
2. Young EJ. Brucella Species. In: Mandell, Bennett, & Dolin: Principles and Practice of Infectious Diseases. 6 ed. Mandell GL, Douglas RG, Bennett JE, Eds. Churchill Livingstone, Philadelphia, 2005: 2670-2673.
3. Sözen TH. Brucellosis. In: Infeksiyon Hastalιklarι ve Mikrobiyolojisi. 2 ed. Topçu AW, Söyletir G, Doǧanay M, Eds. Nobel Tip Kitabevieri, Istanbul, 2002: 636-641 (Textbook section in Turkish).
4. Young EJ. Overview of Brucellosis. Clin Infect Dis 21: 283-289, 1995.
5. Mantur BG, Mangalgi SS, Mulimani M. Brucella melitensis - a sexually transmissible agent? Lancet 347: 1763, 1996.
6. Smits HL, Kadri SM. Brucellosis in India: a deceptive infectious disease. Indian J Med Res 122: 375-384, 2005.
7. Colmenero JD, Reguera JM, Martos F, et al. Complications associated with Brucella melitensis infection: a study of 530 cases. Medicine (Baltimore) 75: 195-211, 1996.
8. McLean DR, Russell N, Khan MY. Neurobrucellosis: clinical and therapeutic features. Clin Infect Dis 15: 582-590, 1992.
9. Pappas G, Papadimitriou P, Akritidis N, Christou L, Tsianos EV The new global map of human brucellosis. Lancet Infect Dis 6: 91-99, 2006.
10. Shakir RA, Al-Din AS, Araj GF, Lulu AR, Mousa AR, Saadah MA. Clinical categories of neurobrucellosis. A report on 19 cases. Brain 110 (Pt 1): 213-223, 1987.
11. Solera J, Martinez-Alfaro E, Espinosa A. Recognition and optimum treatment of brucellosis. Drugs 53: 245-256, 1997.
12. Samdani PG, Patil S. Neurobrucellosis. Indian Pediatr 40: 565-568, 2003.
13. Yüce A, Alp-Çavuşlu S, Yapar N, Çakιr N. Brucellosis: Evaluation of 55 case. (article in Turkish). Klimik Derg 19: 13-7, 2006.
14. Şencan I, Bahtiyar Z, Yazιcι Y. A case of lumbar epidural abscess due to Brucellosis which mimics disk hernia. İnfeks Derg 18: 113-115, 2004 (in Turkish).
15. Ersöz-Arat M, Karsen H, Bakιrcι A, Akdeniz H. A case of neurobrucellosis with coma. Klimik Derg 219: 36-37, 2006 (in Turkish).
16. Cesur S, Çapar Y, Demir P, et al. Retrospective evaluation of 104 cases with Brucellosis. İnfeks Derg 18: 169-173, 200 (in Turkish).
17. Geyik MF, Kökoǧlu ÖF, Hoşoǧlu S, Ayaz C. The evaluation of 154 patients with Brucellosis. Dicle Tip Derg 29: 23-29, 2002 (in Turkish).
18. Heper Y, Yilmaz E, Akalin H, Mistik R, Helvaci S. Neurobrucellosis: evaluation of 9 cases. Klimik Derg 17: 99-102, 2004 (article in Turkish).
19. Kochar DK, Kumawat BL, Agarwal N, et al. Meningoencephalitis in brucellosis. Neurol India 48: 170-173, 2000.
20. DeMott J. Immunology: cerebrospinal fluid protein. In: Laboratory Test Handbook. 5 ed. Lexi-Comp, Inc, Hudson, Cleveland, 2001: 517.
21. Demott J. Chemistry: Cerebrospinal fluid glucose. In: Laboratory Test Handbook.,5 ed. Lexi-Comp, Int, Hudson, Cleveland, 2001: 140.
22. Tunkel AR, Scheld WM. Acute Meningitis. In: Principles and Practice of Infections Diseases. 6 ed. Mandell G, Bennett J, Dolin R, Churchill Livingstone, Philadelphia, 2005: 1084-1126.
23. Arda B, Sipahi OR, Atalay S, Ulusoy S. Pooled analysis of 2,408 cases of acute adult purulent meningitis from Turkey. Med Princ Pract 17: 76-79, 2008.
24. Hesseling AC, Marais BJ, Cotton MF. A child with neurobrucellosis. Ann Trop, Paediatr 23: 145-148, 2003.
25. Keihani-Douste Z, Daneshjou K, Ghasemi M. A quadriplegic child with multiple brain abscesses: case report of neurobrucellosis. Med Sci Monit 12: CS119-CS 122, 2006.
26. Vajramani GV, Nagmoti MB, Patil CS. Neurobrucellosis presenting as an intra-medullary spinal cord abscess. Ann Clin Microbiol Antimicrob 4: 14, 2005.
27. Cagatay A, Karadeniz A, Ozsut H, Eraksoy H, Calangu S. Hearing loss in patient with neurobrucellosis. South Med J 99: 1305-1306, 2006.
28. Thomas R, Kameswaran M, Murugan V, Okafor BC. Sensorineural hearing loss in neurobrucellosis. J Laryngol Otol 107: 1034-1036, 1993.
29. Malik GM. A clinical study of brucellosis in adults in the Asir region of southern Saudi Arabia. Am J Trop Med Hyg 56: 375-377, 1997.
30. Tümtürk A, Yetkin MA, Tülek N, Kilic D. The value of serum aglutination test and enzyme linked immunosorbent assay IgM and IgG antibodies to Brucella in diagnosis and follow-up of Brucellosis. Klimik Derg 17: 107-112, 2004 (in Turkish).
31. Bouza E, Garcia de, la Torre M, Parras F, Guerrero A, Rodriguez-Creixems M, Gobernado J. Brucellar meningitis. Rev Infect Dis 9: 810-822, 1987.
32. Baldi PC, Araj GF, Racaro GC, Wallach JC, Fossati CA. Detection of antibodies to Brucella cytoplasmic proteins in the cerebrospinal fluid of patients with neurobrucellosis. Clin Diagn Lab Immunol 6: 756-759, 1999.
33. Sanchez-Sousa A, Torres C, Campello MG, et al. Serological diagnosis of neurobrucellosis. J Clin Pathol 43: 79-81, 1990.
34. Colmenero JD, Queipo-Ortuno MI, Reguera JM, Baeza G, Salazar JA, Morata P. Real time polymerase chain reaction: a new powerful tool for the diagnosis of neurobrucellosis. J Neurol Neurosurg Psychiatry 76: 1025-1027, 2005.
35. Erdem HA, Aksoy B, Kilic S, et al. Profiles of biochemical parameters in central nervous system fluid during the therapeutic courses of adult Mycobacteriurn tuberculosis meningitis. Scand J Infect Dis 38: 710-712, 2006.
36. CDC. CDC reported tuberculosis in the United States. US Department of Health and Human Services. 2004 September 2005.
37. al-Deeb SM, Yaqub BA, Sharif HS, Motaery KR. Neurotuberculosis: a review. Clin Neurol Neurosurg 94 (Suppl): S30-S33, 1992.
38. Al-Sous MW, Bohlega S, Al-Kawi MZ, Alwatban J, McLean DR. Neurobrucellosis: clinical and-neuroimaging correlation. AJNR Am J Neuroradiol 25: 395-401, 2004.
39. Akdeniz H, Irmak H, Anlar O. Demiroz AP, Central nervous system brucellosis: presentation, diagnosis and treatment. J Infect 36: 297-301, 1998.
40. Kochar DK, Agarwal N, Jain N, Sharma BV, Rastogi A, Meena CB. Clinical profile of neurobrucellosis - a report on 12 cases from Bikaner north-west India). J Assoc Physicians India 48: 376-380, 2000.